Biote (BTMD) EBITDA (2021 - 2026)

Biote (BTMD) has reported EBITDA for 6 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBITDA rose 84250.0% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at -$8.8 million (up 43.87% YoY), while the FY2025 annual figure was $8.3 million, up 718.66% from the prior year.
• EBITDA came in at $3.4 million for Q1 2026 at Biote, up from -$20.6 million in the prior quarter.
• The five-year high for EBITDA was $68.7 million in Q4 2022, with the low at -$85.3 million in Q2 2022.
• Average EBITDA over 5 years is -$1.1 million, with a median of $6000.0 recorded in 2022.
• Across the five-year window, EBITDA plunged 852980.0% in 2022 and soared 84250.0% in 2026, its largest moves.
• Year by year, EBITDA stood at $68.7 million in 2022, then sank by 91.84% to $5.6 million in 2023, then plunged by 596.63% to -$27.9 million in 2024, then climbed by 25.93% to -$20.6 million in 2025, then soared by 116.32% to $3.4 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $3.4 million, -$20.6 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.